NO874989D0 - Fremgangsmaate for fremstilling av tabletter eller kapsler som inneholder et super-desintegrasjonsmiddel. - Google Patents

Fremgangsmaate for fremstilling av tabletter eller kapsler som inneholder et super-desintegrasjonsmiddel.

Info

Publication number
NO874989D0
NO874989D0 NO1987874989A NO874989A NO874989D0 NO 874989 D0 NO874989 D0 NO 874989D0 NO 1987874989 A NO1987874989 A NO 1987874989A NO 874989 A NO874989 A NO 874989A NO 874989 D0 NO874989 D0 NO 874989D0
Authority
NO
Norway
Prior art keywords
desint
migrant
tablets
super
procedure
Prior art date
Application number
NO1987874989A
Other languages
English (en)
Other versions
NO175884C (no
NO874989L (no
NO175884B (no
Inventor
Coenraad F Lerk
Gerad Klaas Bolhuis
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO874989L publication Critical patent/NO874989L/no
Publication of NO874989D0 publication Critical patent/NO874989D0/no
Publication of NO175884B publication Critical patent/NO175884B/no
Publication of NO175884C publication Critical patent/NO175884C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO874989A 1986-04-01 1987-11-30 Fremgangsmåte for fremstilling av en presset tablett som inneholder methylprednisolon og et super-desintegrasjonsmiddel NO175884C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84662086A 1986-04-01 1986-04-01
PCT/US1987/000302 WO1987005804A1 (en) 1986-04-01 1987-02-17 Methylprednisolone/sodium carboxymethyl starch tablet composition

Publications (4)

Publication Number Publication Date
NO874989L NO874989L (no) 1987-11-30
NO874989D0 true NO874989D0 (no) 1987-11-30
NO175884B NO175884B (no) 1994-09-19
NO175884C NO175884C (no) 1994-12-28

Family

ID=25298443

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874989A NO175884C (no) 1986-04-01 1987-11-30 Fremgangsmåte for fremstilling av en presset tablett som inneholder methylprednisolon og et super-desintegrasjonsmiddel

Country Status (8)

Country Link
EP (1) EP0301006B1 (no)
JP (1) JPH01501934A (no)
KR (1) KR880701098A (no)
AU (1) AU7084587A (no)
DK (1) DK167341B1 (no)
HK (1) HK58497A (no)
NO (1) NO175884C (no)
WO (1) WO1987005804A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
DE4290300T1 (de) * 1991-01-30 1993-10-07 Wellcome Found Wasserdispergierbare Tabletten
DE69330392T2 (de) * 1992-04-03 2001-11-08 Nippon Kayaku K.K., Tokio/Tokyo Cytarabine Ocfosfate enthaltende harte Kapsel
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
GB2292079B (en) * 1994-08-12 1998-07-15 Flexpharm Ltd Coated prednisolone preparation for the treatment of inflamatory bowel disease
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
UA72207C2 (uk) 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
DE19855203A1 (de) * 1998-11-30 2000-05-31 Kurt Heinz Bauer Coprozessiertes Polysaccharidprodukt
DE19922537A1 (de) * 1999-05-10 2000-11-16 Roland Bodmeier Darreichungsform zur Applikation in Körperöffnungen
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
KR100882156B1 (ko) * 2003-08-08 2009-02-06 아지노모토 가부시키가이샤 나테글리니드 함유 제제
US9925139B2 (en) 2004-04-22 2018-03-27 Acucort Ab Pharmaceutical compositions for acute glucocorticoid therapy
EP1916995B2 (en) * 2005-07-29 2022-06-29 Stichting Groningen Centre for Drug Research Ph-controlled pulsatile delivery system, methods for preparation and use thereof
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
JP6037687B2 (ja) * 2011-07-08 2016-12-07 サノフィ株式会社 グリメピリドを含有する口腔内崩壊錠
BE1021446B1 (nl) * 2015-01-06 2015-11-24 Stasisport Pharma Nv Methylprednisolon tablet en werkwijze
CN106265568B (zh) * 2016-08-30 2018-08-10 林州中农颖泰生物肽有限公司 一种水溶性醋酸地塞米松片及其制备方法
CN109925288A (zh) * 2017-12-18 2019-06-25 江苏开元药业有限公司 一种糖皮质激素药物片剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2200778B2 (de) * 1971-01-13 1974-04-18 Sandoz Ag, Basel (Schweiz) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
ATE13486T1 (de) * 1980-11-12 1985-06-15 Ciba Geigy Ag Schnellzerfallende arzneimittel-presslinge.
GB8403360D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions

Also Published As

Publication number Publication date
WO1987005804A1 (en) 1987-10-08
NO175884C (no) 1994-12-28
HK58497A (en) 1997-05-09
KR880701098A (ko) 1988-07-25
NO874989L (no) 1987-11-30
NO175884B (no) 1994-09-19
DK167341B1 (da) 1993-10-18
DK624287A (da) 1987-11-27
EP0301006B1 (en) 1992-05-06
JPH01501934A (ja) 1989-07-06
AU7084587A (en) 1987-10-20
DK624287D0 (da) 1987-11-27
EP0301006A1 (en) 1989-02-01

Similar Documents

Publication Publication Date Title
NO874989L (no) Fremgangsmaate for fremstilling av tabletter eller kapsler som inneholder et super-desintegrasjonsmiddel.
NO175286C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat som omfatter dobbeltveggede mikrokapsler
NO870579L (no) Fremgangsmaate for fremstilling av indolizin-derivater.
NO167282C (no) Analogifremgangsmaate for fremstilling av nye 8-substituerte 2-aminotetraliner.
FI881978A0 (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
NO872035L (no) Fremgangsmaate for fremstilling av mesofase-bek.
NO872712D0 (no) Fremgangsmaate for fremstilling av kalsiumholdige preparater.
NO883054L (no) Fremgangsmaate for fremstilling av farmasoeytisk preparat inneholdende somatostatinanaloger.
NO874467D0 (no) Fremgangsmaate for fremstilling av 3-pyrrolidinoler.
NO870866L (no) Fremgangsmÿte for fremstilling av et terapeutisk kombinasjonspreparat.
NO874355D0 (no) Fremgangsmaate for fremstilling av glycolipid som inneholder n-glycolylneuraminsyre.
NO872158L (no) Fremgangsmaate ved fremstilling av nye aromatiske naftylderivater.
NO872809L (no) FremgangsmŸte ved fremstilling av 5-amino-alicylsyre.
NO873514L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
NO873400D0 (no) Fremgangsmaate for fremstilling av sulfidfri alkalivaeske.
NO873339D0 (no) Fremgangsmaate til fremstilling av hydrogenperoksyd.
NO872094D0 (no) Fremgangsmaate ved fremstilling av dbh-inhiberende forbindelser.
ES2016824B3 (es) Poliuretanos preparados a partir de polioles que contienen cristales liquidos y proceso para la preparacion de los mismos.
NO872690D0 (no) Fremgangsmaate for fremstilling av mercaptoacylprolin.
NO874199D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinonderivater.
ES2023670B3 (es) Procedimiento de preparacion de una mezcla que contiene ciclohexanol y ciclohexanona a partir de ciclohexano.
NO874617D0 (no) Fremgangsmaate til fremstilling av 2,6-diamino-3-halogenobenzylpyridiner.
NO880345L (no) Fremgangsmaate for fremstilling av alkyl-tert-butyletere.
IT8319993A0 (it) Composizioni farmaceutiche contenenti composti a scheletro flavanonico, procedimento per lapreparazione di detti composti e nuovi composti ottenuti.